In one month they'll update us on the progress of trials for Breezula and Winlevi.
http://www.cassiopea.com/investor-relations/financial-calendar.aspx
According to the presentation below, they should have started the Breezula phase II DR study by then...
Not sure if you guys saw it, but the last time we heard from Dr. Naughton about HSC was November 2016, when she did an interview with onemedmarket.com.
Can't link due to new account: www dot onemednews dot com/2016/11/19/dr-gail-naughton-histogen/
The interesting bits are:
So I guess...